The University of Texas MD Anderson Cancer Center
Dr. Dasari is a medical oncologist in the Dept of Gastrointestinal Medical Oncology at the University of Texas MD Anderson Cancer Center .
As a member of Southwest Oncology Group (SWOG) and NRG Oncology, he serves on their GI, Colorectal Cancers and Neuroendocrine Committees.
He serves as the SWOG subcommittee co-Chair for NET and on the NET Task Force
His primary research focus is in phase I-III clinical trial development using novel therapeutics inclusive of blood and tissue correlatives for biomarker discovery and enhanced drug utilization in the treatment of gastrointestinal malignancies with a focus on colorectal and neuroendocrine cancers.
He currently leads several ongoing trials in neuroendocrine tumors and colorectal cancers
Session 10: Debate: Pancreatic NETs: PRRT vs Chemotherapy - PRRT
Friday, March 31, 2023
11:30 AM – 11:45 AM ET
Session 10: Debate: Pancreatic NETs: PRRT vs Chemotherapy - Discussion
Friday, March 31, 2023
12:00 PM – 12:15 PM ET
Session 11: Advances in Neuroendocrine Tumors (NETs)
Friday, March 31, 2023
1:15 PM – 2:00 PM ET
Session 12: Debate: Pancreatic NETs: PRRT vs Chemotherapy - PRRT
Thursday, August 3, 2023
2:45 PM – 3:00 PM ET
Session 12: Debate: Pancreatic NETs: PRRT vs Chemotherapy - Discussion
Thursday, August 3, 2023
3:15 PM – 3:30 PM ET
Session 5: Advances in Neuroendocrine Tumors (NETs)
Thursday, September 28, 2023
1:35 PM – 2:10 PM ET
Thursday, September 28, 2023
2:10 PM – 2:20 PM ET
Session 15: Debate: Pancreatic NETs: PRRT vs Chemotherapy - PRRT
Friday, September 29, 2023
4:05 PM – 4:20 PM ET
Session 15: Debate: Pancreatic NETs: PRRT vs Chemotherapy - Discussion
Friday, September 29, 2023
4:35 PM – 4:50 PM ET